
News|Articles|December 1, 2001
Bioterror response to alter pharmaceutical development and marketing
Uncle Sam is poised to authorize more than $1 billion to buy medicines and vaccines for the national pharmaceutical stockpile, and federal agencies are gearing up to spend millions more on research related to infectious disease. In response, the pharmaceutical industry is assessing how these developments may alter the way it does business.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Predictions for 2026 from Marci Chodroff, M.D., Jeffrey Casberg, RPh, M.S., and others
2
Top 5 type 1 diabetes news articles of 2025
3
FDA issues third rejection of bevacizumab to treat wet AMD
4
Predictions for 2026 from Lucille Accetta, RPh, M.P.H., MBA, A.J. Loiacono and Allan Pannier, Pharm.D. MBA
5




















































